{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:58:38Z","timestamp":1776124718762,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011733","name":"Liga Portuguesa Contra o Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011733","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funda\u00e7\u00e3o Rui Os\u00f3rio de Castro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-025-01151-w","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:11:43Z","timestamp":1764346303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient-derived tumoroids recapitulate the morphologic and molecular features of pediatric brain tumors"],"prefix":"10.1038","volume":"9","author":[{"given":"B\u00e1rbara","family":"Soares-Ferreira","sequence":"first","affiliation":[]},{"given":"Joana","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Anabela","family":"Ferro","sequence":"additional","affiliation":[]},{"given":"Beatriz","family":"Esteves","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Roberto","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Josu\u00e9","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Arnaud","family":"Da Cruz Paula","sequence":"additional","affiliation":[]},{"given":"Yingjie","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Maria Teresa","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Lara","family":"Coutinho","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9 Filipe","family":"Maia","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"MJ Gil","family":"Da Costa","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Lima","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"1151_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"1151_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101733","volume":"71","author":"F Erdmann","year":"2021","unstructured":"Erdmann, F. et al. Childhood cancer: survival, treatment modalities, late effects and improvements over time. Cancer Epidemiol. 71, 101733 (2021).","journal-title":"Cancer Epidemiol."},{"key":"1151_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2018.10.PEDS18377","volume":"23","author":"IF Pollack","year":"2019","unstructured":"Pollack, I. F., Agnihotri, S. & Broniscer, A. Childhood brain tumors: current management, biological insights, and future directions. J. Neurosurg. Pediatr. 23, 261\u2013273 (2019).","journal-title":"J. Neurosurg. Pediatr."},{"key":"1151_CR4","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1055-9965.EPI-20-1443","volume":"30","author":"M Adel Fahmideh","year":"2021","unstructured":"Adel Fahmideh, M. & Scheurer, M. E. Pediatric brain tumors: descriptive epidemiology, risk factors, and future directions. Cancer Epidemiol. Biomark. Prev. 30, 813\u2013821 (2021).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1151_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1470-2045(19)30800-9","volume":"21","author":"E Suh","year":"2020","unstructured":"Suh, E. et al. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the childhood cancer survivor study. lancet Oncol. 21, 421\u2013435 (2020).","journal-title":"lancet Oncol."},{"key":"1151_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","volume":"37","author":"S Ryall","year":"2020","unstructured":"Ryall, S. et al. Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell 37, 569\u2013583.e565 (2020).","journal-title":"Cancer Cell"},{"key":"1151_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature25795","volume":"555","author":"X Ma","year":"2018","unstructured":"Ma, X. et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature 555, 371\u2013376 (2018).","journal-title":"Nature"},{"key":"1151_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1158\/2159-8290.CD-19-1030","volume":"10","author":"M Clarke","year":"2020","unstructured":"Clarke, M. et al. Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discov. 10, 942\u2013963 (2020).","journal-title":"Cancer Discov."},{"key":"1151_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12187-5","volume":"10","author":"AS Guerreiro Stucklin","year":"2019","unstructured":"Guerreiro Stucklin, A. S. et al. Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas. Nat. Commun. 10, 4343 (2019).","journal-title":"Nat. Commun."},{"key":"1151_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-018-1837-8","volume":"136","author":"A Reinhardt","year":"2018","unstructured":"Reinhardt, A. et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A\/B and ATRX alterations. Acta Neuropathol. 136, 273\u2013291 (2018).","journal-title":"Acta Neuropathol."},{"key":"1151_CR11","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1634\/theoncologist.2017-0242","volume":"22","author":"A Johnson","year":"2017","unstructured":"Johnson, A. et al. Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures. Oncologist 22, 1478\u20131490 (2017).","journal-title":"Oncologist"},{"key":"1151_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N. et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803\u2013820 (2016).","journal-title":"Acta Neuropathol."},{"key":"1151_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"1151_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer 18, 407\u2013418 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"1151_CR15","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers, H. Modeling development and disease with organoids. Cell 165, 1586\u20131597 (2016).","journal-title":"Cell"},{"key":"1151_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob, F. et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180, 188\u2013204.e122 (2020).","journal-title":"Cell"},{"key":"1151_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100345","volume":"2","author":"CM Gamboa","year":"2021","unstructured":"Gamboa, C. M. et al. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening. STAR Protoc. 2, 100345 (2021).","journal-title":"STAR Protoc."},{"key":"1151_CR18","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","volume":"15","author":"F Jacob","year":"2020","unstructured":"Jacob, F., Ming, G. L. & Song, H. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing. Nat. Protoc. 15, 4000\u20134033 (2020).","journal-title":"Nat. Protoc."},{"key":"1151_CR19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00401-020-02226-7","volume":"140","author":"A Golebiewska","year":"2020","unstructured":"Golebiewska, A. et al. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathol. 140, 919\u2013949 (2020).","journal-title":"Acta Neuropathol."},{"key":"1151_CR20","first-page":"vdad152","volume":"5","author":"M Verduin","year":"2023","unstructured":"Verduin, M. et al. Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. Neurooncol. Adv. 5, vdad152 (2023).","journal-title":"Neurooncol. Adv."},{"key":"1151_CR21","unstructured":"Ferreira, B., Peixoto, J. & Lima, J. Reference Module in Biomedical Sciences (Elsevier, 2023)."},{"key":"1151_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.semcancer.2021.06.008","volume":"84","author":"M Blattner-Johnson","year":"2022","unstructured":"Blattner-Johnson, M., Jones, D. T. W. & Pfaff, E. Precision medicine in pediatric solid cancers. Semin Cancer Biol. 84, 214\u2013227 (2022).","journal-title":"Semin Cancer Biol."},{"key":"1151_CR23","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41388-023-02681-y","volume":"42","author":"I Paassen","year":"2023","unstructured":"Paassen, I. et al. Atypical teratoid\/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities. Oncogene 42, 1661\u20131671 (2023).","journal-title":"Oncogene"},{"key":"1151_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00335-y","volume":"6","author":"H Peterziel","year":"2022","unstructured":"Peterziel, H. et al. Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. NPJ Precis Oncol. 6, 94 (2022).","journal-title":"NPJ Precis Oncol."},{"key":"1151_CR25","first-page":"164","volume":"3","author":"CM Coffin","year":"1990","unstructured":"Coffin, C. M., Braun, J. T., Wick, M. R. & Dehner, L. P. A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression. Mod. Pathol. 3, 164\u2013170 (1990).","journal-title":"Mod. Pathol."},{"key":"1151_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469\u2013474 (2018).","journal-title":"Nature"},{"key":"1151_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41568-019-0223-8","volume":"20","author":"V Hovestadt","year":"2020","unstructured":"Hovestadt, V. et al. Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat. Rev. Cancer 20, 42\u201356 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1151_CR28","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1093\/neuonc\/noad125","volume":"25","author":"T Milde","year":"2023","unstructured":"Milde, T. et al. Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation. Neuro Oncol. 25, 1920\u20131931 (2023).","journal-title":"Neuro Oncol."},{"key":"1151_CR29","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.medj.2021.08.005","volume":"2","author":"S Bose","year":"2021","unstructured":"Bose, S., Clevers, H. & Shen, X. Promises and challenges of organoid-guided precision medicine. Med. 2, 1011\u20131026 (2021).","journal-title":"Med."},{"key":"1151_CR30","doi-asserted-by":"crossref","unstructured":"Yoo, J. et al. The extent of necrosis in brain metastases may predict subtypes of primary cancer and overall survival in patients receiving craniotomy. Cancers (Basel) 14, 1694 (2022).","DOI":"10.3390\/cancers14071694"},{"key":"1151_CR31","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202318199","volume":"15","author":"C Lago","year":"2023","unstructured":"Lago, C. et al. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments. EMBO Mol. Med. 15, e18199 (2023).","journal-title":"EMBO Mol. Med."},{"key":"1151_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/neuonc\/noab273","volume":"24","author":"KG Abdullah","year":"2022","unstructured":"Abdullah, K. G. et al. Establishment of patient-derived organoid models of lower-grade glioma. Neuro Oncol. 24, 612\u2013623 (2022).","journal-title":"Neuro Oncol."},{"key":"1151_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00578-x","volume":"8","author":"L Pedace","year":"2024","unstructured":"Pedace, L. et al. Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling. NPJ Precis. Oncol. 8, 92 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"1151_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15155-6","volume":"11","author":"C Calandrini","year":"2020","unstructured":"Calandrini, C. et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat. Commun. 11, 1310 (2020).","journal-title":"Nat. Commun."},{"key":"1151_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller, M. et al. Glioma. Nat. Rev. Dis. Prim. 10, 33 (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1151_CR36","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"164","author":"D Sturm","year":"2016","unstructured":"Sturm, D. et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164, 1060\u20131072 (2016).","journal-title":"Cell"},{"key":"1151_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85385-1","volume":"11","author":"B Carvalho","year":"2021","unstructured":"Carvalho, B. et al. The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab. Sci. Rep. 11, 6067 (2021).","journal-title":"Sci. Rep."},{"key":"1151_CR38","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/term.3248","volume":"15","author":"SW Zhang","year":"2021","unstructured":"Zhang, S. W. et al. An efficient and user-friendly method for cytohistological analysis of organoids. J. Tissue Eng. Regen. Med. 15, 1012\u20131022 (2021).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"1151_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","volume":"3","author":"M Eiraku","year":"2008","unstructured":"Eiraku, M. et al. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3, 519\u2013532 (2008).","journal-title":"Cell Stem Cell"},{"key":"1151_CR40","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology 141, 1762\u20131772 (2011).","journal-title":"Gastroenterology"},{"key":"1151_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262\u2013265 (2009).","journal-title":"Nature"},{"key":"1151_CR42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"1151_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira, B. et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat. Commun. 7, 11479 (2016).","journal-title":"Nat. Commun."},{"key":"1151_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9891","volume":"6","author":"A Roy","year":"2015","unstructured":"Roy, A. et al. Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney. Nat. Commun. 6, 8891 (2015).","journal-title":"Nat. Commun."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01151-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01151-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01151-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:03:23Z","timestamp":1764349403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01151-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1151"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-01151-w","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}